Skip to main content

Table 5 IPA results

From: STaRRRT: a table of short tandem repeats in regulatory regions of the human genome

Top Bio Functions

Molecules (n)

p-value

Diseases and disorders

Neurological disease

443

1.27E-04 - 4.94E-02

Psychological disorders

236

1.81E-04 - 4.94E-02

Developmental disorder

132

9.19E-04 - 4.24E-02

Antimicrobial response

29

1.38E-03 - 2.00E-02

Infectious disease

418

2.25E-03 - 4.17E-02

Molecular and cellular functions

Cellular movement

325

3.39E-04 - 4.81E-02

Cell death and survival

501

6.18E-04 - 4.83E-02

Cell-to-cell signaling and interaction

119

1.07E-03 - 4.81E-02

Cellular development

290

1.17E-03 - 4.37E-02

Cellular growth and proliferation

192

1.47E-03 - 4.81E-02

Physiological system development and functions

Cardiovascular system development and function

167

7.56E-06 - 4.70E-02

Organismal development

146

3.20E-05 - 4.37E-02

Humoral immune response

12

1.38E-03 - 4.81E-02

Reproductive system development and function

31

1.47E-03 - 4.17E-02

Hematological system development and function

107

1.74E-03 - 4.81E-02

Top 20 canonical pathways

Ratio

p-value

NGF signaling

34/111 (0.306)

3.16E-03

Pyridoxal 5'-phosphate salvage pathway

22/62 (0.355)

4.22E-03

Reelin signaling in neurons

26/82 (0.317)

6.29E-03

Neuropathic pain signaling in dorsal horn neurons

31/102 (0.304)

6.92E-03

GNRH signaling

38/135 (0.281)

7.00E-03

Cellular effects of sildenafil (Viagra)

37/127 (0.291)

9.28E-03

Calcium signaling

48/189 (0.254)

1.01E-02

Factors promoting cardiogenesis in vertebrates

27/91 (0.297)

1.27E-02

Synaptic long-term depression

39/142 (0.275)

1.51E-02

B cell receptor signaling

43/162 (0.265)

1.95E-02

FGF signaling

26/88 (0.295)

2.01E-02

mTOR signaling

49/189 (0.259)

2.06E-02

Gɑq signaling

40/157 (0.255)

2.33E-02

Dopamine-DARPP32 feedback in cAMP signaling

43/161 (0.267)

2.40E-02

D-myo-inositol (1,4,5)-triphosphate biosynthesis

10/26 (0.385)

2.66E-02

PPARɑ/RXRɑ activation

44/173 (0.254)

2.86E-02

NF-κB activation by viruses

22/79 (0.278)

3.18E-02

Xenobiotic metabolism signaling

66/268 (0.246)

3.20E-02

Antioxidant action of vitamin C

27/98 (0.276)

3.43E-02

Maturity onset diabetes of young (MODY) signaling

8/22 (0.364)

3.64E-02

  1. Results from comparison of the set of transcripts containing STaRRRT STRs with the reference set Ingenuity Knowledge Base are shown. For “Top Bio Functions”, the number of molecules (n) relates to genes containing STaRRRT STRs in each enriched functional group. For “Top Canonical Pathways”, the number of STR-containing genes, relative to the total number of genes for each canonical pathway, is shown as a fraction and as a ratio (in brackets). Results shown are limited to those with a p-value less than 0.05 for the “Top Bio Functions” and the 20 most significant results with a p-value less than 0.05 for the “Top Canonical Pathways”.